Cutaneous Rhabdomyosarcoma May Mask Melanoma - Summary - MDSpire

Cutaneous Rhabdomyosarcoma May Mask Melanoma

  • By

  • Andrea Surnit

  • April 28, 2026

  • 3 min

Share

Objective:

To evaluate rare cutaneous tumors initially diagnosed as epithelioid or pleomorphic rhabdomyosarcoma and assess their potential reclassification as transdifferentiated melanoma.

Approach:
    Key Findings:
    • 10 of the 13 tumors were reclassified as transdifferentiated melanoma.
    • All tumors expressed desmin and myogenin; S100 was negative in 12 of 12, SOX10 in 10 of 10, Melan A in 9 of 9, and HMB45 in 5 of 5.
    • DNA methylation profiling successfully clustered 7 tumors with desmoplastic melanoma.
    • All evaluable tumors had a DNA ultraviolet light signature.
    • TERT promoter mutations were identified in 5 of 7 sequenced cases.
    Interpretation:

    Melanoma can lose conventional markers and mimic sarcoma while retaining molecular evidence of melanocytic lineage, indicating the need for careful diagnostic consideration.

    Limitations:
    • Small sample size and retrospective design.
    • Incomplete molecular testing across all cases.
    • Biopsy-heavy specimen set.
    • Mutational signature analysis not clinically validated.
    • Methylation profiling limitations, including inconclusive matches.
    Conclusion:

    The majority of cutaneous epithelioid/pleomorphic rhabdomyosarcomas in this study exhibit genetic/epigenetic phenotypes consistent with transdifferentiated melanoma, highlighting the importance of comprehensive molecular testing.

    Sources:

Original Source(s)

Related Content